Veteran CDMO executive to guide next phase of global expansion and operational excellence for lentiviral vector manufacturer.

Lentiviral vector: Viral particles derived from lentiviruses, engineered to deliver therapeutic genetic material into host cells. Transduction: The process by which foreign genetic material is ...

OXB completes acquisition of remaining stake in US subsidiary Progression to full ownership aligns with global strategy and ...

CSL will consolidate its R&D teams around six sites located in biotech hubs as the company looks to boost external ...

ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today ...

The Hopewell site is equipped to support clinical-stage development, process-development, and scaleup for cell and gene therapy programs.

Spanish gene therapy specialist VIVEbiotech has named Patricio Massera as its new president, bringing in a seasoned CDMO ...

Natalia Elizalde, PhD, is chief business development officer for VIVEbiotech, a Spanish CDMO that specialises in lentiviral vector production. Elizalde has specialised in business development in ...

About Vector BioMed Vector BioMed is a public benefit corporation redefining lentiviral vector manufacturing for accessible, affordable cell and gene therapies. Spun out of the nonprofit Caring ...

A gene-therapy approach using lentiviral vectors (LVs) was tested in neonatal mice to transfer genes into blood stem cells (haematopoietic stem cells), that were travelling from the liver to the ...

EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 70 countries worldwide. For more ...

ProBio has opened its flagship Cell and Gene Therapy Center of Excellence at the Princeton West Innovation Campus in Hopewell ...